Christine J. Saoud

Array ( [id] => 4386382 [patent_doc_number] => 06262237 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Methods of antagonizing the binding of protocadherin-42' [patent_app_type] => 1 [patent_app_number] => 9/099639 [patent_app_country] => US [patent_app_date] => 1998-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 1 [patent_no_of_words] => 45728 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262237.pdf [firstpage_image] =>[orig_patent_app_number] => 099639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1517898 [patent_doc_number] => 06500920 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Inhibitor of transforming growth factor and A method of inhibiting the biological effects of transforming growth factor' [patent_app_type] => B1 [patent_app_number] => 09/095637 [patent_app_country] => US [patent_app_date] => 1998-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 5738 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500920.pdf [firstpage_image] =>[orig_patent_app_number] => 09095637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1486062 [patent_doc_number] => 06365711 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Methods and reagents for modulating TGF- superfamily signalling' [patent_app_type] => B1 [patent_app_number] => 09/087134 [patent_app_country] => US [patent_app_date] => 1998-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 21165 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365711.pdf [firstpage_image] =>[orig_patent_app_number] => 09087134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355774 [patent_doc_number] => 06168791 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-02 [patent_title] => 'Antibodies that bind immunomodulators' [patent_app_type] => 1 [patent_app_number] => 9/082797 [patent_app_country] => US [patent_app_date] => 1998-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 18434 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/168/06168791.pdf [firstpage_image] =>[orig_patent_app_number] => 082797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1398356 [patent_doc_number] => 06531450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-11 [patent_title] => 'Use of MP52 or MP121 for treating and preventing diseases of the nervous system' [patent_app_type] => B2 [patent_app_number] => 08/981490 [patent_app_country] => US [patent_app_date] => 1998-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11394 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531450.pdf [firstpage_image] =>[orig_patent_app_number] => 08981490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1549347 [patent_doc_number] => 06346388 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2' [patent_app_type] => B1 [patent_app_number] => 09/072993 [patent_app_country] => US [patent_app_date] => 1998-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8043 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346388.pdf [firstpage_image] =>[orig_patent_app_number] => 09072993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174451 [patent_doc_number] => 20020155111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'EXPRESSION OF IMMUNOGLOBULIN-CYTOKIN FUSION PROTEINS IN MALIGNANT B CELLS' [patent_app_type] => new [patent_app_number] => 09/064026 [patent_app_country] => US [patent_app_date] => 1998-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3720 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155111.pdf [firstpage_image] =>[orig_patent_app_number] => 09064026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 501705 [patent_doc_number] => 07205397 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-17 [patent_title] => 'Proteins and methods for producing the proteins' [patent_app_type] => utility [patent_app_number] => 09/062113 [patent_app_country] => US [patent_app_date] => 1998-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 21330 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/205/07205397.pdf [firstpage_image] =>[orig_patent_app_number] => 09062113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 644736 [patent_doc_number] => 07118750 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-10 [patent_title] => 'Modified TNF-alpha molecules, DNA encoding such and vaccines comprising such modified TNF-alpha and DNA' [patent_app_type] => utility [patent_app_number] => 09/060294 [patent_app_country] => US [patent_app_date] => 1998-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 21 [patent_no_of_words] => 11810 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/118/07118750.pdf [firstpage_image] =>[orig_patent_app_number] => 09060294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1574377 [patent_doc_number] => 06468766 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Aortic carboxypeptidase-like polypeptide' [patent_app_type] => B1 [patent_app_number] => 09/060482 [patent_app_country] => US [patent_app_date] => 1998-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 14874 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/468/06468766.pdf [firstpage_image] =>[orig_patent_app_number] => 09060482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6876870 [patent_doc_number] => 20010007023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-05 [patent_title] => 'BONE MORPHOGENETIC PROTEIN AND FIBROBLAST GROWTH FACTOR COMPOSITIONS AND METHODS FOR THE INDUCTION OF CARDIOGENESIS' [patent_app_type] => new-utility [patent_app_number] => 09/056513 [patent_app_country] => US [patent_app_date] => 1998-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4770 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0007/20010007023.pdf [firstpage_image] =>[orig_patent_app_number] => 09056513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4303824 [patent_doc_number] => 06251865 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Insulin-like growth factor agonist molecules' [patent_app_type] => 1 [patent_app_number] => 9/052888 [patent_app_country] => US [patent_app_date] => 1998-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 66 [patent_no_of_words] => 53272 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251865.pdf [firstpage_image] =>[orig_patent_app_number] => 052888 [rel_patent_id] =>[rel_patent_doc_number] =>)